BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19751789)

  • 1. Derivation of Biomonitoring Equivalents for di(2-ethylhexyl)phthalate (CAS No. 117-81-7).
    Aylward LL; Hays SM; Gagné M; Krishnan K
    Regul Toxicol Pharmacol; 2009 Dec; 55(3):249-58. PubMed ID: 19751789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation of Biomonitoring Equivalents for di-n-butyl phthalate (DBP), benzylbutyl phthalate (BzBP), and diethyl phthalate (DEP).
    Aylward LL; Hays SM; Gagné M; Krishnan K
    Regul Toxicol Pharmacol; 2009 Dec; 55(3):259-67. PubMed ID: 19751787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation of Biomonitoring Equivalents for cyfluthrin.
    Hays SM; Aylward LL; Gagné M; Krishnan K
    Regul Toxicol Pharmacol; 2009 Dec; 55(3):268-75. PubMed ID: 19751788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomonitoring equivalents for di-isononyl phthalate (DINP).
    Hays SM; Aylward LL; Kirman CR; Krishnan K; Nong A
    Regul Toxicol Pharmacol; 2011 Jul; 60(2):181-8. PubMed ID: 21466828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomonitoring Equivalents for bisphenol A (BPA).
    Krishnan K; Gagné M; Nong A; Aylward LL; Hays SM
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):18-24. PubMed ID: 20541576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomonitoring Equivalents (BE) dossier for cadmium (Cd) (CAS No. 7440-43-9).
    Hays SM; Nordberg M; Yager JW; Aylward LL
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S49-56. PubMed ID: 18579269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomonitoring Equivalents (BE) dossier for toluene (CAS No. 108-88-3).
    Aylward LL; Barton HA; Hays SM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S27-36. PubMed ID: 18583006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomonitoring Equivalents (BE) dossier for 2,4-dichlorophenoxyacetic acid (2,4-D) (CAS No. 94-75-7).
    Aylward LL; Hays SM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S37-48. PubMed ID: 18579270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomonitoring equivalents for DDT/DDE.
    Kirman CR; Aylward LL; Hays SM; Krishnan K; Nong A
    Regul Toxicol Pharmacol; 2011 Jul; 60(2):172-80. PubMed ID: 21466830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomonitoring Equivalents for triclosan.
    Krishnan K; Gagné M; Nong A; Aylward LL; Hays SM
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):10-7. PubMed ID: 20541577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomonitoring Equivalents for benzene.
    Hays SM; Pyatt DW; Kirman CR; Aylward LL
    Regul Toxicol Pharmacol; 2012 Feb; 62(1):62-73. PubMed ID: 22178585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomonitoring equivalents for hexachlorobenzene.
    Aylward LL; Hays SM; Gagné M; Nong A; Krishnan K
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):25-32. PubMed ID: 20547196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomonitoring equivalents for inorganic arsenic.
    Hays SM; Aylward LL; Gagné M; Nong A; Krishnan K
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):1-9. PubMed ID: 20547195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internal phthalate exposure over the last two decades--a retrospective human biomonitoring study.
    Wittassek M; Wiesmüller GA; Koch HM; Eckard R; Dobler L; Müller J; Angerer J; Schlüter C
    Int J Hyg Environ Health; 2007 May; 210(3-4):319-33. PubMed ID: 17400024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Biomonitoring Equivalents to interpret human biomonitoring data in a public health risk context.
    Hays SM; Aylward LL
    J Appl Toxicol; 2009 May; 29(4):275-88. PubMed ID: 19115313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principles of risk assessment for determining the safety of chemicals: recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate.
    Hasegawa R; Koizumi M; Hirose A
    Congenit Anom (Kyoto); 2004 Jun; 44(2):51-9. PubMed ID: 15198717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure-- an update and latest results.
    Koch HM; Preuss R; Angerer J
    Int J Androl; 2006 Feb; 29(1):155-65; discussion 181-5. PubMed ID: 16466535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Derivation of biomonitoring equivalent (BE) values for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds: a screening tool for interpretation of biomonitoring data in a risk assessment context.
    Aylward LL; Lakind JS; Hays SM
    J Toxicol Environ Health A; 2008; 71(22):1499-508. PubMed ID: 18836925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative risk assessment of phthalate exposure of Danish children and adolescents using the hazard index approach.
    Søeborg T; Frederiksen H; Andersson AM
    Int J Androl; 2012 Jun; 35(3):245-52. PubMed ID: 22320716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomonitoring equivalents for deltamethrin.
    Aylward LL; Krishnan K; Kirman CR; Nong A; Hays SM
    Regul Toxicol Pharmacol; 2011 Jul; 60(2):189-99. PubMed ID: 21466827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.